ID
29002
Description
A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.
Keywords
Versions (1)
- 2/20/18 2/20/18 -
Copyright Holder
GlaxoSmithKline (GSK)
Uploaded on
February 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518
Visit 2 Check for study continuation and laboratory tests
- StudyEvent: ODM
Description
Laboratory tests
Alias
- UMLS CUI-1
- C0022885
Similar models
Visit 2 Check for study continuation and laboratory tests
- StudyEvent: ODM
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
C0805733 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
C0205160 (UMLS CUI [1,4])
C0679006 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])